In late 2026, the industry is pivoting toward "AI-Driven Gait Analysis." This year, a radical new class of AI-powered processors inside bionic knees can analyze terrain 1,000 times per second, ad...
In late 2026, the industry is pivoting toward "Pharmacogenomic Profiling." This year, a radical new class of genetic tests has been launched that can identify "C5 Polymorphisms"—rare genetic vari...
